These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1967651)
21. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Lyon RA; Glennon RA; Titeler M Psychopharmacology (Berl); 1986; 88(4):525-6. PubMed ID: 2871581 [TBL] [Abstract][Full Text] [Related]
22. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats. Nash JF; Arora RC; Schreiber MA; Meltzer HY Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633 [TBL] [Abstract][Full Text] [Related]
23. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM. Glennon RA Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460 [TBL] [Abstract][Full Text] [Related]
24. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
25. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Johnson MP; Nichols DE Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831 [TBL] [Abstract][Full Text] [Related]
26. Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists. Glennon RA; Higgs R; Young R; Issa H Pharmacol Biochem Behav; 1992 Dec; 43(4):1099-106. PubMed ID: 1361990 [TBL] [Abstract][Full Text] [Related]
27. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat. Shannon HE Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411 [TBL] [Abstract][Full Text] [Related]
28. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Huang X; Nichols DE Eur J Pharmacol; 1993 Jul; 238(2-3):291-6. PubMed ID: 8104811 [TBL] [Abstract][Full Text] [Related]
29. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat. Hekmatpanah CR; McKenna DJ; Peroutka SJ Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011 [TBL] [Abstract][Full Text] [Related]
30. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons. Evans SM; Johanson CE Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843 [TBL] [Abstract][Full Text] [Related]
31. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP; Conarty PF; Nichols DE Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125 [TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus properties of alpha-ethyltryptamine optical isomers. Hong SS; Young R; Glennon RA Pharmacol Biochem Behav; 2001; 70(2-3):311-6. PubMed ID: 11701202 [TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA). Broadbent J; Appel JB; Michael EK; Ricker JH Behav Pharmacol; 1992 Oct; 3(5):443-454. PubMed ID: 11224147 [TBL] [Abstract][Full Text] [Related]
34. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats. Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Baker LE; Broadbent J; Michael EK; Matthews PK; Metosh CA; Saunders RB; West WB; Appel JB Behav Pharmacol; 1995 Apr; 6(3):263-275. PubMed ID: 11224335 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA). Steele TD; Katz JL; Ricaurte GA Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813 [TBL] [Abstract][Full Text] [Related]